Legend Biotech (LEGN) Amortization (2020 - 2025)
Legend Biotech (LEGN) posted Amortization of -$20.8 million for Q3 2025, down 690.91% on a QoQ basis from $3.5 million in Q2 2025, and up 57.67% year-over-year from -$13.2 million in Q3 2024.
Legend Biotech (LEGN) has 6 years of Amortization data on file, last reported at -$20.8 million in Q3 2025.
- In Q3 2025, Amortization rose 57.67% year-over-year to -$20.8 million; the TTM figure through Sep 2025 stood at -$99.1 million (up 62.05% YoY), while the FY2022 annual figure was -$402.5 million, down 11.37% from the prior year.
- Amortization fell to -$20.8 million in Q3 2025, from $3.5 million in the prior quarter.
- Across five years, Amortization topped out at $3.5 million in Q2 2025 and bottomed at -$402.5 million in Q4 2022.
- A 5-year average of -$93.7 million and a median of -$73.1 million in 2021 frame the typical range for Amortization.
- Annual changes were most pronounced in 2024 — Amortization plunged 2529.46% — and 2025, when it jumped 137.88%.
- Year by year, Amortization stood at -$361.4 million in 2021, then decreased by 11.37% to -$402.5 million in 2022, then surged by 100.5% to $2.0 million in 2023, then plunged by 2529.46% to -$49.1 million in 2024, then surged by 57.67% to -$20.8 million in 2025.
- The last three Amortization figures came in at -$20.8 million (Q3 2025), $3.5 million (Q2 2025), and -$32.7 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.75 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -20.81 Mn |
| Sep 30, 2025 | -20.81 Mn |
| Jun 30, 2025 | 3.52 Mn |
| Jun 30, 2025 | 3.52 Mn |
| Mar 31, 2025 | -32.70 Mn |
| Mar 31, 2025 | -32.70 Mn |
| Sep 30, 2024 | -49.15 Mn |
| Sep 30, 2024 | -49.15 Mn |
| Jun 30, 2024 | -9.30 Mn |
| Jun 30, 2024 | -9.30 Mn |
| Mar 31, 2024 | -91.66 Mn |
| Mar 31, 2024 | -91.66 Mn |
| Sep 30, 2023 | 2.02 Mn |
| Sep 30, 2023 | 2.02 Mn |
| Jun 30, 2023 | 2.02 Mn |
| Jun 30, 2023 | 2.02 Mn |
| Mar 31, 2023 | -111.12 Mn |
| Mar 31, 2023 | -111.12 Mn |
| Dec 31, 2022 | -402.54 Mn |
| Dec 31, 2022 | -402.54 Mn |
| Sep 30, 2022 | -129.39 Mn |
| Sep 30, 2022 | -129.39 Mn |
| Jun 30, 2022 | -96.26 Mn |
| Jun 30, 2022 | -96.26 Mn |
| Mar 31, 2022 | -64.41 Mn |
| Mar 31, 2022 | -64.41 Mn |
| Dec 31, 2021 | -361.45 Mn |
| Dec 31, 2021 | -361.45 Mn |
| Sep 30, 2021 | -77.34 Mn |
| Sep 30, 2021 | -77.34 Mn |
| Jun 30, 2021 | -81.72 Mn |
| Jun 30, 2021 | -81.72 Mn |
| Mar 31, 2021 | -73.08 Mn |
| Mar 31, 2021 | -73.08 Mn |
| Dec 31, 2020 | -212.50 Mn |
| Dec 31, 2020 | -212.50 Mn |
| Sep 30, 2020 | -62.50 Mn |
| Sep 30, 2020 | -62.50 Mn |